These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17611179)

  • 1. [Hepatitis B and liver transplantation].
    Fehérvári I; Görög D; Kóbori L; Varga M; Sárvári E; Gerlei Z; Nemes B
    Orv Hetil; 2007 Jul; 148(28):1299-302. PubMed ID: 17611179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
    Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
    J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
    Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
    Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
    Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation.
    Segovia R; Sánchez-Fueyo A; Rimola A; Grande L; Bruguera M; Costa J; Soguero C; Uriz J
    Liver Transpl; 2001 Feb; 7(2):106-12. PubMed ID: 11172393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mutants of the pre-c region of the hepatitis B virus associated with severe recurrence after liver transplantation].
    Féray C
    Gastroenterol Clin Biol; 1995 Nov; 19(11):964-5. PubMed ID: 8746067
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver transplantation for hepatitis B-induced liver disease: long-term outcome and effectiveness of antiviral therapy for prevention of recurrent hepatitis B infection.
    Perrakis A; Förtsch T; Del Medico A; Croner RS; Vassos N; Yedibela S; Lohmüller C; Zopf S; Hohenberger W; Müller V
    Transplant Proc; 2013 Jun; 45(5):1953-6. PubMed ID: 23769081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of hepatitis B in liver transplants treated with antiviral therapy.
    Marzano A; Debernardi-Venon W; Smedile A; Brunetto MR; Torrani Cerenzia MR; Actis GC; Zamboni F; Ghisetti V; Piantino P; David E; Salizzoni M; Rizzetto M
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):77-81. PubMed ID: 9615271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical course of de novo hepatitis B infection after pediatric liver transplantation.
    Su WJ; Ho MC; Ni YH; Wu JF; Jeng YM; Chen HL; Wu YM; Hu RH; Chang MH; Lee PH
    Liver Transpl; 2010 Feb; 16(2):215-21. PubMed ID: 20104496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
    Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of intrahepatic hepatitis B virus DNA and correlation with hepatic necroinflammation and fibrosis.
    Wong DK; Yuen MF; Tse E; Yuan H; Sum SS; Hui CK; Lai CL
    J Clin Microbiol; 2004 Sep; 42(9):3920-4. PubMed ID: 15364969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hepatitis B].
    Telegdy L
    Orv Hetil; 2004 Nov; 145(45):2293-6. PubMed ID: 15573894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.
    Perrillo R; Rakela J; Dienstag J; Levy G; Martin P; Wright T; Caldwell S; Schiff E; Gish R; Villeneuve JP; Farr G; Anschuetz G; Crowther L; Brown N
    Hepatology; 1999 May; 29(5):1581-6. PubMed ID: 10216146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.
    Taltavull TC; Chahri N; Verdura B; Gornals J; Lopez C; Casanova A; Cañas C; Figueras J; Casais LA
    Transpl Int; 2005 Jul; 18(7):879-83. PubMed ID: 15948869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
    Sun LY; Zhu ZJ; Qu W; Sun XY; Rao W; Liu Y
    Hepatogastroenterology; 2014 Oct; 61(135):2047-51. PubMed ID: 25713909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum.
    Mariscal LF; Rodríguez-Iñigo E; Bartolomé J; Castillo I; Ortiz-Movilla N; Navacerrada C; Pardo M; Pérez-Mota A; Graus J; Carreño V
    J Med Virol; 2004 Jun; 73(2):177-86. PubMed ID: 15122790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection.
    Tufano M; Liccardo D; Riva S; Candusso M; Torre G; Iorio R
    Transpl Infect Dis; 2013 Apr; 15(2):E81-4. PubMed ID: 23387823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
    Fung J; Cheung C; Chan SC; Yuen MF; Chok KS; Sharr W; Dai WC; Chan AC; Cheung TT; Tsang S; Lam B; Lai CL; Lo CM
    Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.